calla
Early access · Research project

Bladder health should be easier to navigate.

Calla is an early-stage project exploring better ways to organise health experiences, understand the evidence behind bladder health conditions, and prepare for medical appointments.

Not a medical service. See our current status.

Where Calla is now

Calla is currently in product research and development. It is not providing healthcare, medical advice, diagnosis, treatment, practitioner services or emergency support.

Why Calla is being built

It shouldn't take this much effort to be understood.

Calla grew from my own experience of living with ongoing bladder and urinary symptoms while trying to be taken seriously. I went through repeated appointments and saw countless doctors before I found someone who really listened. I was told it could be many different things, or simply part of being a woman. Because I was young, I often felt treated as though I was anxious or overreacting, even when the pain was affecting every part of my life.

It disrupted work, study, plans, food, social life, relationships and intimacy. I spent so much time researching, tracking and trying to explain what was happening that it began to take over everything else.

Calla is being built to explore whether evidence-led education, better organisation and appointment preparation could make that process less overwhelming. It is not a promise of diagnosis or treatment. It is an attempt to help other women feel less alone and less consumed while navigating care.

What Calla is exploring

Research and product concepts, not available services

None of the following exist as a public product yet. These are areas we are researching and prototyping. People who join the early-access list may receive occasional product-development updates. People who separately opt in may also be invited to take part in product research.

Evidence-led education

Research concepts for explaining what the current evidence does and doesn't say about bladder health conditions, in plain language.

Organising symptoms and experiences

Early ideas for helping people structure their own symptom history over time, so it's easier to look back on and describe.

Appointment preparation

Concepts for turning a scattered history into a clear, shareable summary to bring into a consultation.

Diagnostic education

Plain-language explainers on how common tests and diagnostic pathways work, so they're less confusing going in.

Better navigation of support

Research into how people currently find and choose care, and where that journey tends to break down.

Join the list

Get early access updates

Join the early-access list to hear about our progress. No spam, unsubscribe any time.

Calla's early-access list is operated by Bonnie Waller in Victoria, Australia. We collect your email address, consent choices and any optional name or country information to manage the list and send occasional product-development updates. If you separately opt in, we may also contact you about product-research interviews. MailerLite processes subscriber information on our behalf, including outside Australia. Required information is needed to join. You can unsubscribe or withdraw consent at any time. Please do not submit health information. Read our Privacy Notice or contact calla.bonnie@outlook.com.

FAQ

Questions, answered plainly

What is Calla right now?

Calla is an early-stage research and product-development project. This site exists to share what we're exploring and to invite people to join an early-access list; it is not a live product or service.

Is Calla a healthcare provider?

No. Calla is not providing healthcare, medical advice, diagnosis, treatment, practitioner services, or emergency support. Nothing on this site should be used to make a medical decision.

Will Calla diagnose me or recommend treatment?

No. What's described on this site are research and product concepts we're exploring, not available services. If they're built, they are intended to help you organise information and prepare for care you access elsewhere, not to replace a clinician.

What happens when I join the list?

You'll be added to our early-access list using MailerLite, our email platform. Joining the list requires consent to receive product updates. Separately, you can choose whether you're happy to be contacted about product-research interviews. You can unsubscribe or withdraw either consent at any time.

What information do you collect?

Just what's in the form: your email address, and optionally your first name and country. We don't ask for symptoms, diagnoses, medication information, or any other health details, and you shouldn't submit any through this form.

When will Calla launch?

We don't have a launch date to share yet. Joining the list is the best way to hear about progress as it happens.